Curated gurus reporting this holding
A curated subset of well-known investors — not the full institutional ownership.
- Bridgewater Associates58,217주2026-06-30 · 증감 +1266주
Axsome Therapeutics company information
액섬 테라퓨틱스NASDAQ:AXSM · Nasdaq · Healthcare$179.25-1.55%
2026-10-02 closeAxsome Therapeutics's company information is shown as of 2026-10-02. It is a security listed on Nasdaq, ticker AXSM. There are 14 published related companies.
About this company
Axsome Therapeutics last closed at $179.25 (-1.55%) on 2026-10-02. Listed on Nasdaq.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F is quarterly and may be filed up to 45 days later.
Suppliers, competitors and related stocks
- Eli LillyCompetitor
중추신경계(CNS) 및 우울증·신경과학 영역의 대형 제약 경쟁사
- Johnson & JohnsonCompetitor
정신건강·신경과학 포함 전반적 제약 경쟁사
- PfizerCompetitor
우울증·통증·CNS 치료제 시장의 대형 경쟁사
- AbbVieCompetitor
CNS 및 신경과학 포트폴리오를 가진 대형 제약 경쟁사
- Bristol Myers SquibbCompetitor
신경정신과 및 바이오제약 영역의 대형 경쟁사
- Teva Pharmaceutical IndustriesCompetitor
신경계·중추신경계 제네릭/전문의약품 경쟁사
- Takeda PharmaceuticalCompetitor
신경과학·정신질환 치료제 개발 및 글로벌 제약 경쟁사
- Sunovion PharmaceuticalsCompetitor
정신건강·CNS 치료제 분야의 경쟁사
- LundbeckCompetitor
우울증·정신질환 중심의 전문 제약 경쟁사
- AlkermesCompetitor
CNS 및 정신질환 치료제 영역의 경쟁사
- Neurocrine BiosciencesCompetitor
CNS·신경과학 신약 개발 경쟁사
- Supernus PharmaceuticalsCompetitor
중추신경계 및 신경계 질환 치료제 경쟁사
- Intra-Cellular TherapiesCompetitor
정신분열증·우울증 등 정신건강 치료제 경쟁사
- Janssen PharmaceuticalsCompetitor
CNS·정신질환 치료제 포함 대형 제약 부문 경쟁사
Major stocks in the same sector
2026-10-03 dataset
📦 ETFs holding this stock
by weight · top-10 constituents basisPassive money holding this stock ≈ $10M(lower bound — top-10 basis, not a forecast)
Factual holdings info from daily disclosures — not a recommendation.
Look up another stock →Quantus Signal · live data · not investment advice · Privacy Policy